Ross S. Berkowitz - Concepedia

Author

Ross S. Berkowitz

Also Known As

Berkowitz, Ross, Berkowitz, Ross S., Chandrajit P. Raut, Christopher Crum, Colleen Feltmate, D. P. Goldstein, Daniel Cramer, Elizabeth I O Garner, Jill S. Barnholtz-Sloan, Jordonna Fulop

706

Publications

61.8K

Citations

H-Index

221

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Dana-Farber Cancer Institute Dana-Farber Brigham Cancer Center Massachusetts General Hospital

About

Ross S. Berkowitz is an author at Brigham and Women's Hospital specializing in medicine, obstetrics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	62	197	12.3K
2	Health Sciences	9	9	1.1K
3	Engineering	2	2	909
4	Education	1	1	35
5	Humanities	1	1	24

Ross S. Berkowitz

304

Publications

24.5K

Citations

H-Index

Page 1

	Year	Citations
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer Robert C. Bast, Thomas L. Klug, Elena St. John, New England Journal of Medicine	1983	2.2K
Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship David W. Kindelberger, Yonghee Lee, Alexander Miron, The American Journal of Surgical Pathology	2007	1.1K
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. Pamela J. Olúbùnmi Smith, L S Wise, Ross S. Berkowitz, Journal of Biological Chemistry 3T3-l1 AdipocytesInsulin ReceptorInsulin SignalingMetabolic SyndromeSignaling Pathway	1988	511
Primary Fallopian Tube Malignancies in <i>BRCA</i>-Positive Women Undergoing Surgery for Ovarian Cancer Risk Reduction Michael J. Callahan, Christopher P. Crum, Fabíola Medeiros, Journal of Clinical Oncology	2007	485
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids Sarah J. Hill, Brennan Decker, Emma A. Roberts, Cancer Discovery	2018	442
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Update on the diagnosis and management of gestational trophoblastic disease Michael J. Seckl, Ross S. Berkowitz, Yang Xiang, International Journal of Gynecology & Obstetrics	2018	427
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy Joan Montero, Kristopher A. Sarosiek, Joseph D. DeAngelo, Cell MedicineApoptosisPharmacologyCell DeathAnti-cancer Agent	2015	363

Page 1